Evidence map›Paper›PMID 30712460›Full record

ArticleThe Journal of international medical research2020

Identification of aberrant gene expression during breast ductal carcinoma

Guiqin Song, Lang He, Xiaolin Yang, Yan Yang, Xiaoming Cai, Kang Liu, Gang Feng

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of international medical research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. FYB1-targeted modulation of CAPG promotes AML progression.Molecular and cellular biochemistry · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Translational andrology and urology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Guiqin SongInstitute of Tissue Engineering and Stem Cells, Nanchong Central Hospital, the Second Clinical Medical College, North Sichuan Medical College, Nanchong, Sichuan, P.R. China.
Lang HeDepartment of Oncology, the Fifth People's Hospital of Chengdu, The Second Clinical Medical School of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, P.R. China.
Xiaolin YangDepartment of Biology, North Sichuan Medical College, Nanchong, Sichuan, P.R. China.
Yan YangSichuan Chidingshengtong Biotechnology Co., Ltd., Chengdu, Sichuan, P.R. China.
Xiaoming CaiDepartment of Biology, North Sichuan Medical College, Nanchong, Sichuan, P.R. China.
Kang LiuInstitute of Tissue Engineering and Stem Cells, Nanchong Central Hospital, the Second Clinical Medical College, North Sichuan Medical College, Nanchong, Sichuan, P.R. China.ORCID https://orcid.org/0000-0002-4640-0849
Gang FengInstitute of Tissue Engineering and Stem Cells, Nanchong Central Hospital, the Second Clinical Medical College, North Sichuan Medical College, Nanchong, Sichuan, P.R. China.
North Sichuan Medical University · CNChengdu University of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Disease ProgressionGene Expression Regulation, NeoplasticBreast NeoplasmsCarcinoma, Ductal, BreastCarcinoma in SituCluster AnalysisDatabases, GeneticDown-RegulationFemaleGene Expression ProfilingHumansNeoplasm ProteinsReproducibility of ResultsSignal TransductionUp-RegulationNeoplasm Proteinsbreast cancerdifferentially expressed genesDuctal carcinoma in situinvasive ductal carcinomametastasisOncomine analysisrecurrence

Identifiers

PMID30712460
PMCPMC7140215
OpenAlexW2912489135

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.